Anti-SLC25A22 monoclonal antibody

Pre-made anti-SLC25A22 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC25A22/SLC25A22 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1671-Ab-1/ GM-Tg-hg-IP1671-Ab-2Anti-Human SLC25A22 monoclonal antibodyHuman
GM-Tg-rg-IP1671-Ab-1/ GM-Tg-rg-IP1671-Ab-2Anti-Rat SLC25A22 monoclonal antibodyRat
GM-Tg-mg-IP1671-Ab-1/ GM-Tg-mg-IP1671-Ab-2Anti-Mouse SLC25A22 monoclonal antibodyMouse
GM-Tg-cynog-IP1671-Ab-1/ GM-Tg-cynog-IP1671-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC25A22 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1671-Ab-1/ GM-Tg-felg-IP1671-Ab-2Anti-Feline SLC25A22 monoclonal antibodyFeline
GM-Tg-cang-IP1671-Ab-1/ GM-Tg-cang-IP1671-Ab-2Anti-Canine SLC25A22 monoclonal antibodyCanine
GM-Tg-bovg-IP1671-Ab-1/ GM-Tg-bovg-IP1671-Ab-2Anti-Bovine SLC25A22 monoclonal antibodyBovine
GM-Tg-equg-IP1671-Ab-1/ GM-Tg-equg-IP1671-Ab-2Anti-Equine SLC25A22 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1671-Ab-1/ GM-Tg-hg-IP1671-Ab-2; GM-Tg-rg-IP1671-Ab-1/ GM-Tg-rg-IP1671-Ab-2;
GM-Tg-mg-IP1671-Ab-1/ GM-Tg-mg-IP1671-Ab-2; GM-Tg-cynog-IP1671-Ab-1/ GM-Tg-cynog-IP1671-Ab-2;
GM-Tg-felg-IP1671-Ab-1/ GM-Tg-felg-IP1671-Ab-2; GM-Tg-cang-IP1671-Ab-1/ GM-Tg-cang-IP1671-Ab-2;
GM-Tg-bovg-IP1671-Ab-1/ GM-Tg-bovg-IP1671-Ab-2; GM-Tg-equg-IP1671-Ab-1/ GM-Tg-equg-IP1671-Ab-2
Products NameAnti-SLC25A22 monoclonal antibody
Formatmab
Target NameSLC25A22
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC25A22 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1671-Ag-1Recombinant multi-species GHC1/ SLC25A22/ EIEE3 protein
    ORF Viral VectorvGMLP004059human SLC25A22 Lentivirus particle
    ORF Viral VectorpGMLP004059human SLC25A22 Lentivirus plasmid
    ORF Viral VectorpGMLPm004133mouse Slc25a22 Lentivirus plasmid
    ORF Viral VectorvGMLPm004133mouse Slc25a22 Lentivirus particle


    Target information

    Target IDGM-IP1671
    Target NameSLC25A22
    Gene ID79751,68267,309111,700463,119864201,101098990,504371,100147341
    Gene Symbol and Synonyms1300006L01Rik,DEE3,EIEE3,GC-1,GC1,NET44,RGD1307826,SLC25A22
    Uniprot AccessionQ9H936,A0A0G2K5L2,Q08DK4
    Uniprot Entry NameGHC1_HUMAN,A0A0G2K5L2_RAT,GHC1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000177542
    Target ClassificationN/A

    The target: SLC25A22, gene name: SLC25A22, also named as EIEE3, GC-1, GC1, NET44. This gene encodes a mitochondrial glutamate carrier. Mutations in this gene are associated with early infantile epileptic encephalopathy. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.